含转移因子(TF)的白细胞提取物透析液(DLE)具有调节受者对特定抗原的细胞介导免疫(CMI)能力的效应,亦能增强受者非特异性CMI功能。两者对治疗疾病均有裨益。近来Viza氏证明TF可以诱导巨噬细胞产生免疫核糖核酸(iRNA),而iRNA有诱导B淋巴细胞产生特异性抗体的能力。TF的治疗效应已逐渐引起临床医师的注意,并已在临床上应用。在某些情况下可收到惊人的疗效。 Leukocyte extract dialysate (DLE) with transfer factor (TF) has the effect of modulating the recipient’s ability to mediate cell-mediated immunity (CMI) of a particular antigen and also enhances non-specific CMI function in recipients. Both are beneficial to the treatment of disease. Recently, Viza demonstrated that TF can induce macrophages to produce iRNA, and iRNA has the ability to induce B lymphocytes to produce specific antibodies. The therapeutic effect of TF has gradually attracted the attention of clinicians and has been applied clinically. In some cases can receive astonishing effects.